Short Active Lives Survey in Chronic Lung Conditions

Short Active Lives Survey in Chronic Lung Conditions: an Exploratory Study

Short Actives Lives Survey is a common tool used to measure physical activity in the UK population. Self-reported measures such as the Short Active Lives Survey can be prone to bias. As such, during project evaluations, benefits may be exaggerated due to over-reporting of physical activity or downplayed due to underreporting of physical activity. There is also a lack of research reporting the typical short-term and long-term changes in physical activity (measured by the Short Active Lives Survey) in people with chronic lung conditions who are not receiving support to become active (i.e. usual care, control groups). Accelerometers are small lightweight activity monitors that can be worn on the waist. These monitors are known to provide accurate and reliable objective assessment of physical activity in people with lung conditions.

This research study will recruit a cohort of inactive people with lung conditions and determine changes in physical activity measured by both the Short Active Lives Survey and one of the most valid accelerometers used in people with lung conditions (Actigraph GT3X). The study will also evaluate how these physical activity measures relate to general health (health status and health care use) of people with lung conditions over 12 months. This study will provide information on the usefulness of using the Short Active Lives Survey in the future for measuring physical activity in people with lung conditions.

Study Overview

• Status: Completed
• Conditions: Lung Diseases

• Study Type: Observational
• Enrollment (Actual): 80

Contacts and Locations

Study Locations

• United Kingdom
  • Lincolnshire
    • Lincoln, Lincolnshire, United Kingdom, LN6 7TS
      • University of Lincoln

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

The eligibility criteria has been designed to be as broad as possible so that findings can be generalisable to the wider population of inactive people with lung conditions. The main study population will be recruited via convenience sampling at the participant identification centres within Lincolnshire Community Health Services, South Lincolnshire CCG, South West Lincolnshire CCG, Lincolnshire East CCG, Lincolnshire West CCG and United Lincolnshire Hospitals NHS Trust.

Description

Inclusion Criteria:

• Diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
• Physically inactive defined as completing less than 30 minutes ore more of moderate intensity equivalent physical activity per week (measured by the Short Active Lives Survey)

Exclusion Criteria:

• Adults without a diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
• Age < 18 Years
• Completing 30 minutes or more of moderate intensity equivalent (MIE) physical activity per week
• Inability or unwillingness to sign informed consent

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Usual Care; People with a chronic lung condition who are physically inactive

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Minutes of self-reported moderate intensity equivalent physical activity per week	Short Active Lives Survey	Baseline to 12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Accelerometer measured physical activity: time (minutes per day) spent in moderate intensity activity	Actigraph wGT3X-BT	Baseline to 12 months
Accelerometer measured physical activity: time (minutes per week) spent in light activity	Actigraph wGT3X-BT	Baseline to 12 months
Accelerometer measured physical activity including: time (minutes per week) spent in vigorous activity	Actigraph wGT3X-BT	Baseline to 12 months
Accelerometer measured physical activity: time (minutes per day) spent in sedentary state	Actigraph wGT3X-BT	Baseline to 12 months
Accelerometer measured physical activity: average daily steps	Actigraph wGT3X-BT	Baseline to 12 months
Accelerometer measured physical activity including: daily vector magnitude units	Actigraph wGT3X-BT	Baseline to 12 months
EQ5D index	Based on self-rating of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Each dimension is rated between 1 (no problems) to 5 (unable to/extreme problems). Dimensions are combined to produce a five-digit number describing the individual's health status (ranging from 11111 to 55555). Five digit number converted to an index based on the EQ-5D-5L value set for England. Index ranges from -0.208 (worst possible health) to 1.000 (best possible health).	Baseline to 12 months
EQ VAS	Self-report of health status on a scale, 0 (worst health) - 100 (best health)	Baseline to 12 months
Cost questionnaire	NHS resource use questionnaire	Baseline to 12 months
Demographics:	Age, gender, ethnicity, comorbidities, social deprivation, MRC degree of breathlessness, oxygen use	Baseline to 12 months

Collaborators and Investigators

• Sponsor: University of Lincoln
• Investigators: Principal Investigator: Arwel W Jones, PhD, University of Lincoln

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2019
• Primary Completion (Actual): November 30, 2020
• Study Completion (Actual): December 31, 2020

Study Registration Dates

• First Submitted: September 3, 2019
• First Submitted That Met QC Criteria: September 3, 2019
• First Posted (Actual): September 6, 2019

Study Record Updates

• Last Update Posted (Actual): April 27, 2021
• Last Update Submitted That Met QC Criteria: April 26, 2021
• Last Verified: January 1, 2020

More Information

Terms related to this study

• Keywords: Health Status; Physical activity
• Additional Relevant MeSH Terms: Respiratory Tract Diseases; Lung Diseases
• Other Study ID Numbers: 190501

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No